OMOlga Borisovna Melashchenko

Olga Borisovna Melashchenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga Borisovna Melashchenko has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Content of RANTES, IL-8 and MIP-1β chemokines in platelet lysates obtained from donor blood

    by Valeria V. Shupletsova, Olga B. Melashchenko, Natalya D. Gazatova, Olga G. Khaziakhmatova, Alexandra S. Minina, Anastassiya M. Kopteva, Nina A. Kabanchuk, Tatyana N. Pervenetskaya, Andrey G. Goncharov, Larisa S. Litvinova, et al.

    Growth supplements obtained from animal sera have a rather variable range of a specific growth factor contents and are subject to potential contamination. Moreover, the growth supplements obtained from animal raw materials contain a composition of proteins, vitamins and microelements necessary for full-fledged cell growth, and one may overcome these drawbacks by replacing them with a product obtained from human donor blood. Platelet lysate contains biologically active molecules derived from endogenous granules of these blood elements. Concentration of distinct biocomponents in the resulting product is variable, depending not only on gender and blood group, but also on other, as yet unidentified individual characteristics. The aim of this study was to examine the content of some chemokines, in particular, RANTES, MIP-1β and IL-8, in platelet lysates obtained from healthy donors. The highest concentrations of MIP-1β cytokine were noted in Rh-negative donors, in females with blood group III, and in males with the IV. blood group. The highest IL-8 contents in platelet lysate were also recorded in Rh-negative, group IV men and women. Platelet lysate of volunteers with the II blood group (men, Rh-negative; women, Rh-positive) contained the highest amount of RANTES. Significant differences were found between the MIP-1β levels in thrombolysate of men and women with the second A (II), and AB (IV) Rh-negative blood groups; between women of the third B (III) blood group with different Rh factors. Moreover, statistically significant differences were found in the RANTES/CCL5 chemokine values in the thrombolysate for the groups of men and women with the second A (II) [with R (+) and R (-)], and AB (IV) blood group (Rh+). Interestingly, in Rh (-) men with the first 0 (I) and second A (II) blood groups, the content of chemokine RANTES/CCL5 in the blood thrombolysate significantly exceeded similar values in the blood obtained from Rh-positive men. Conclusion: The relationship between the donors’ belonging to a particular blood group and the content of these chemokines is not yet clear. Future studies with deep bioinformatics analysis will reveal the unclear interrelations between these indicators.


  • MANIFESTATION OF CHRONIC INFLAMMATORY COMPONENTS IN METABOLIC SYNDROME USING THE EXAMPLE OF CHANGES IN THE PROINFLAMMATORY ACTIVITY OF MONOCYTES/MACROPHAGES IN AN EXPERIMENTAL CELL MODEL

    by V.V. Malashchenko, O.G. Khaziakhmatova, K.A. Yurova, M.M. Bograya, N.D. Gazatova, M.A. Vulf, N.M. Todosenko, O.B. Melashchenko, M.A. Beletskaya, L.S. Litvinova

    Metabolic syndrome (MS) is one of the most common and socially significant problems of the 21st century. Its progression contributes to the onset and development of a number of serious comorbidities, such as insulin resistance/diabetes mellitus, liver and kidney damage, cardiovascular pathologies. Such a broad profile of comorbidities is due to the development of systemic chronic inflammation. The most important cells involved in this process are tissue-resident macrophages. We hypothesise that the negative effects of proinflammatory factors in MS in general may also affect the monocyte-macrophage component of the immune system. The aim of the study is to identify differences in monocyte/macrophage activity in individuals with MS compared to conditionally healthy donors. Materials and methods. Monocyte/macrophage cultures obtained from the whole blood of individuals with MS using the immunomagnetic separation method were used for the study. An experimental in vitro model was developed to determine the sensitivity of immune cells to a proinflammatory stimulus (LPS) as assessed by the production of the cytokines MCP-1, TNF-α, IL-1β, IL-6, IL-8 and IL-10 by the cells. Results and conclusions. A decrease in the activity of peripheral blood monocytes is observed in MS; they show a decreased basal secretion of cytokines, which may indicate a suppression of their cytokine-producing activity due to a high concentration of proinflammatory factors in the circulation in MS. For IL-6 and IL-10, but not for other cytokines studied, an additional increase in LPS-induced secretion by monocytes in MS patients was demonstrated, which could be a consequence of both the «enrichment» of the monocyte subpopulation in the peripheral blood with «intermediate» and «non-classical» monocytes and the potential suppressor activity of IL-6. The correct formation of target groups plays an important role in the in vitro investigation of monocyte/macrophage activity in patients with MS. In particular, grouping MS patients by obesity level (BMI) could be more informative than the option based on grouping data by MS components.

  • The Pathogenic Subpopulation of Th17 Cells in Obesity

    by Natalia Todosenko, Maria Vulf, Kristina Yurova, Daria Skuratovskaia, Olga Khaziakhmatova, Natalia Gazatova, Olga Melashchenko, Olga Urazova, Larisa Litvinova

    Obesity is a metabolic disease characterized by a chronic subclinical inflammatory response associated with an imbalance/dysregulation of cellular homeostasis in response to excessive nutrient intake and accumulation. CD4+ T-lymphocytes form different populations, Th1, Th2, Th9, Th17, Th22, and Treg cells, which have phenotypic and functional differences. Despite the active study of Th17 cells in severe disorders, their role in metabolic disorders, particularly in obesity, is not well understood. Th17 lymphocytes, depending on the microenvironment, can form pathogenic and nonpathogenic subpopulations. Systemic inflammation induces the reprogramming of the transcriptome of normal Th17 cells formed in epithelial tissues, which acquire new properties. A zone of overlapping states exists between IL-17A-producing cells, which does not allow a clear boundary between non-pathogenic Th17 and pathogenic Th17 lymphocytes. We assume that in obesity, the pool of inflammatory pathogenic Th17 cells with cytotoxic potential is a fraction of terminally differentiated memory lymphocytes which is responsible for developing autoimmune reactions.


  • Erythropoietin Directly Affects Human Macrophage Functionality

    by Olga V. Melashchenko, Maxim E. Meniailo, Vladimir V. Malashchenko, Natalya D. Gazatova, Andrei G. Goncharov, Galina V. Seledtsova, Victor. I. Seledtsov

    We studied direct effects of erythropoietin (Epo) on functional properties of human monocytes/macrophages (Mc/Mphs) in vitro. Cells expressing CD14 marker (a co-receptor for bacterial LPS) were isolated from human peripheral blood mononuclear cells (PBMCs) by positive magnetic separation. We showed that Epo treatment reduce the percentages of CD14+ cells, CD124 (alpha subunit of IL-4 receptor)+ cells and CD197 (CCR7) + cells in non-activated Mph cultures without affecting the levels of CD16 (low-affinity Fc-receptor)+ and CD119 (interferon-γ (IFN-γ) receptor)+ cells. Epo also markedly reduced percentages of CD197+ cells in LPS-activated Mc/Mphs, without significantly affecting the expression of all other molecular markers studied. In addition, Epo caused moderate up-regulation of interleukin-1β (IL-1β) and IL-6 production in resting Mc/Mph cultures, as compared to the down-regulation of IL-1β and IL-6 production in LPS-activated cells. No Epo-mediated effects on tumor necrosis factor-α (TNF-α) and IL-10 production were observed. Our data suggests that Epo effects on Mph functionality are largely dependent on the baseline activation status of these cells, and that Epo exerts no distinct direct effects on the particular Mph polarization pathway. This data contributes to better understanding of mechanisms underlying Mph-mediated, anti-inflammatory effects of Epo, which are an important immunotherapeutic target in autoimmune diseases.


  • Interleukin-8 is able to promote pro-inflammatory activity of human monocytes (macrophages)

    by M. E Meniailo, Vv. V Malashchenko, Va. A Shmarov, N. D Gazatova, O. B Melashchenko, A. G Goncharov, G. V Seledtsova, V. I Seledtsov


  • Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophages

    by Maksim Evgenievich Meniailo, Vladimir Vladimirovich Malashchenko, Vyacheslav Anatolievich Shmarov, Natalia Dinislamovna Gazatova, Olga Borisovna Melashchenko, Andrei Gennadievich Goncharov, Galina Viktorovna Seledtsova, Viktor Ivanovich Seledtsov


  • Direct anti-inflammatory effects of granulocyte colony-stimulating factor (G-CSF) on activation and functional properties of human T cell subpopulations in vitro

    by Vladimir Vladimirovich Malashchenko, Maxsim Evgenievich Meniailo, Viacheslav Anatolievich Shmarov, Natalia Dinislamovna Gazatova, Olga Borisovna Melashchenko, Andrei Gennadievich Goncharov, Galina Victorovna Seledtsova, Victor Ivanovich Seledtsov


  • Direct effects of interleukin-8 on growth and functional activity of T lymphocytes

    by Maksim Evgenievich Meniailo, Vladimir Vladimirovich Malashchenko, Viacheslav Anatolievich Shmarov, Natalia Dinislamovna Gazatova, Olga Borisovna Melashchenko, Andrei Gennadievich Goncharov, Galina Victorovna Seledtsova, Victor Ivanovich Seledtsov


  • Open Access

    A ROLE FOR INTERLEUKIN 8 IN DIRECT REGULATION OF T CELL FUNCTIONAL ACTIVITY

    by M. E. Meniailo, V. V. Malashchenko, V. A. Shmarov, N. D. Gasatova, O. B. Melashchenko, A. G. Goncharov, G. V. Seledtsova, V. I. Seledtsov

    CD3+Т-лимфоциты выделяли из мононуклеарных клеток нормальных доноров методом позитивной магнитной сепарации. Показано, что продукция интерлейкина-8 (interleukin-8, IL-8) Т-клетками возрастала в ответ на их активацию частицами, конъюгированными с антителами к молекулам CD3, СD28 и СD2. Исходно рецептор к IL-8 (CXCR1, CD181) экспрессировался на 13,3% Т-лимфоцитов. Активация Т-лимфоцитов приводила к заметному увеличению содержания CD181+ клеток среди CD4+ наивных Т-лимфоцитов, CD4+ терминально-дифференцированных Т-эффекторов и снижению их числа среди CD4+ клеток эффекторной памяти. Активацию Т-лимфоцитов оценивали по экспрессии молекулы CD25 (рецептор к IL-2). Установлено, что IL-8 в диапазоне концентраций 0,01-10,0 нг/мл способен снижать активацию как CD4-, так и CD4+Т-клеток эффекторной памяти и терминально-дифференцированных Т-эффекторов, не оказывая при этом существенного влияния на активацию наивных Т-лимфоцитов и Т-клеток центральной памяти. IL-8 усиливал продукцию активированными Т-клетками IL-2, снижал продукцию IL-10 и существенно не влиял на секрецию IFNγ и IL-4. Полученные данные указывают на значимость IL-8 в прямой регуляции адаптивных Т-клеточных реакций.


  • Direct effects of interleukin-7 on the function of human T cells in vitro

    by Vyacheslav A. Shmarov, Vladimir V. Malashchenko, Maksim E. Meniailo, Natalia D. Gazatova, Natalia M. Todosenko, Olga B. Melashchenko, Andrei G. Goncharov, Victor I. Seledtsov

    СD3+ T lymphocytes were isolated by positive magnetic separation from the peripheral blood of healthy donors. In the absence of any additional activating stimuli, interleukin-7 (IL-7) was shown to augment the levels of T cells expressing CD25 activation marker both in СD4-positive and in CD4-negative effector memory (CD45RA-CD197-) T cell subsets, as well as in terminally differentiated (CD45RA+CD197-) Т cells, without significantly affecting the activation status of naive (CD45RA+CD197+) and central memory (CD45RA-CD197+) T cells. In addition, IL-7 noticeably enhanced the production of IL-2, interferon-γ (IFN-γ), and IL-10, but not IL-4, in T cells. The direct effects of IL-7 on T cell activation induced in vitro by MACSiBead™ particles coated with CD2, CD3, and CD28 antibodies (Abs) were also investigated. Upon cell activation, IL-7 significantly augmented the levels of CD25+ T cells in naive (CD45RA+CD197+), central memory (CD45RA-CD197+), and effector memory (CD45RA-CD197-) T-cell compartments. In addition, IL-7 facilitated activation of СD4- (but not CD4+) terminally differentiated effector (CD45RA+CD197-) Т cells. Finally, IL-7 was found to upregulate the production of IL-2, IFN-γ, IL-4, and IL-10 by activated T cells. In conclusion, we speculate that IL-7 is capable of enhancing functional T cell activity without causing significant functional inbalance between various T cell subsets.